Description

The commercial production of nanomedicines involves challenges related to scalability, reproducibility, safety, and regulatory approvals. It is essential to have access to a preparation method that can produce large quantities of nanomedicines in a scalable way while maintaining a consistently high level of quality and batch-to-batch reproducibility. This book provides comprehensive guidance on the commercial-scale production of nanotechnology-based products, facilities requirements, and quality assurance. Authored by industrial and academic experts Offers regulatory guidance on the chemistry, manufacturing, and controls (CMC) of nanoparticles and commercial translation of nanomedicines from the lab to market Features case studies of successfully marketed nanotechnologies This book serves as a valuable resource for students and researchers in pharmaceutics, pharmaceutical technology, drug delivery, drug targeting, and biomedical engineering.
It also supports industrial personnel working in nanomedicine manufacturing with the latest updates and those seeking to switch or extend their current product range to nanomedicines or start a new venture in nanomedicine production.